Globeflex Capital LP Increased By $385,182 Its Insys Therapeutics Ord (INSY) Position; Cca Industries (NYSEMKT:CAW) SI Increased By 368.57%

August 30, 2017 - By Henry Gaston

Globeflex Capital LP increased Insys Therapeutics Ord (INSY) stake by 108.01% reported in 2016Q4 SEC filing. Globeflex Capital LP acquired 42,798 shares as Insys Therapeutics Ord (INSY)’s stock rose 13.42%. The Globeflex Capital LP holds 82,422 shares with $758,000 value, up from 39,624 last quarter. Insys Therapeutics Ord now has $679.08M valuation. The stock declined 2.29% or $0.22 reaching $9.34 on the news. About 20,049 shares traded. Insys Therapeutics Inc (NASDAQ:INSY) has declined 5.69% since August 30, 2016 and is downtrending. It has underperformed by 22.39% the S&P500.

Cca Industries Incorporated (NYSEMKT:CAW) had an increase of 368.57% in short interest. CAW’s SI was 16,400 shares in August as released by FINRA. Its up 368.57% from 3,500 shares previously. With 24,100 avg volume, 1 days are for Cca Industries Incorporated (NYSEMKT:CAW)’s short sellers to cover CAW’s short positions. The SI to Cca Industries Incorporated’s float is 0.33%. About 6 shares traded. CCA Industries, Inc. (NYSEMKT:CAW) has declined 3.16% since August 30, 2016 and is downtrending. It has underperformed by 19.86% the S&P500.

CCA Industries, Inc. manufactures and distributes health and beauty aid products. The company has market cap of $25.22 million. The Firm is engaged in the sale of products in several health-and-beauty aids over-the-counter drug and remedies, and cosmeceutical categories. It has a 17.53 P/E ratio. Under its brand names, the Company markets several different but categorically related products.

Investors sentiment increased to 1.2 in 2016 Q4. Its up 0.39, from 0.81 in 2016Q3. It is positive, as 21 investors sold INSY shares while 43 reduced holdings. 21 funds opened positions while 34 raised stakes. 27.44 million shares or 9.45% less from 30.31 million shares in 2016Q3 were reported. Parametric Portfolio Assoc Ltd Liability invested in 0% or 19,112 shares. 27,000 are held by Glg Prtn L P. Private Ocean Limited Liability Corporation stated it has 130 shares. Geode Capital Management Ltd Limited Liability Company has 278,131 shares. Community Bancorp Na accumulated 1,000 shares or 0% of the stock. Creative Planning invested in 0% or 4,219 shares. 1.71M are held by Blackrock Fund Advisors. Fincl Bank Of Montreal Can owns 6,600 shares for 0% of their portfolio. Deutsche Bank & Trust Ag has invested 0% of its portfolio in Insys Therapeutics Inc (NASDAQ:INSY). Kcg has invested 0% of its portfolio in Insys Therapeutics Inc (NASDAQ:INSY). Prelude Capital Mngmt Ltd Liability Company has 2,600 shares. Shell Asset Management Com invested 0.01% in Insys Therapeutics Inc (NASDAQ:INSY). 2,048 are owned by Us State Bank De. Fincl Architects reported 0% of its portfolio in Insys Therapeutics Inc (NASDAQ:INSY). Next Fincl Gru Inc Inc holds 1,815 shares.

Among 6 analysts covering Insys Therapeutics (NASDAQ:INSY), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Insys Therapeutics had 17 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, June 1. The company was maintained on Thursday, September 22 by RBC Capital Markets. On Sunday, August 13 the stock rating was maintained by Jefferies with “Buy”. The stock has “Market Outperform” rating by JMP Securities on Wednesday, March 9. As per Thursday, April 14, the company rating was initiated by Janney Capital. As per Tuesday, April 12, the company rating was maintained by Jefferies. The stock of Insys Therapeutics Inc (NASDAQ:INSY) earned “Hold” rating by Piper Jaffray on Tuesday, July 25. As per Wednesday, February 24, the company rating was maintained by Jefferies. The stock of Insys Therapeutics Inc (NASDAQ:INSY) earned “Buy” rating by Jefferies on Friday, June 9. The firm has “Buy” rating by Jefferies given on Thursday, August 4.

Since May 16, 2017, it had 4 insider purchases, and 0 selling transactions for $268,142 activity. 8,000 Insys Therapeutics Inc (NASDAQ:INSY) shares with value of $97,680 were bought by MEYER STEVEN J. On Wednesday, June 14 the insider Motahari Saeed bought $59,955. 4,000 Insys Therapeutics Inc (NASDAQ:INSY) shares with value of $56,575 were bought by Vishnoi Rohit.